Search
for
Sort by
Research 31–60 of 1000+
- Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport
- PROTACs: A novel strategy for cancer drug discovery and development
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- Cold Atmospheric Plasma for Breast Cancer
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Actualités du SOPK
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Controversies in Polycystic Ovary Syndrome
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Molecular mechanisms of asymmetric divisions in mammary stem cells
- Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Impact of Chemotherapeutic Drug on People living with Cancer
- Redefining hormone resistance in prostate cancer
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- The evolution of primary multimodality treatment in resectable breast cancer
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Epigenetic regulation in adult stem cells and cancers
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
- Androgen receptor: A promising therapeutic target in breast cancer